Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine in pediatric bipolar I disorder
NCT01244815Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in bipolar I disorder, sponsored by Organon & Co.. Started Jun 2011; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01244815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244815.